This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Roger J. Porter, MD; William H. Theodore, MD

Arch Intern Med. 1983;143(5):945-947.

Abstract
• Trends in the diagnosis of epilepsy have continued to focus on the fundamental cause of the seizures, as well as the seizure type. It is the latter that determines symptomatic therapy. New drugs have improved the lives of many epileptic patients, and emphasis on nonsedative medications, both new and old, is now possible and desirable in most patients. Finally, new and better drugs are needed for the many severely affected epileptic patients who are not helped by the currently available antiepileptic drugs.

(Arch Intern Med 1983;143:945-947)

Author Affiliations
From the Clinical Epilepsy Section and the Epilepsy Branch, National Institute of Neurological and Communicative Disorders and Stroke (NINCDS), Bethesda, Md.

Footnotes
Accepted for publication Dec 8,1982.

Reprint requests to Epilepsy Branch, NINCDS, Federal Bldg, Room 114, National Institutes of Health, Bethesda, MD 20205 (Dr Porter).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?